Table 1.
Patients’ characteristics
| Cohort | n = 34 |
|---|---|
| Age (years) | |
| Median (range) | 61 (22–76) |
| Gender—n (%) | |
| Female | 14 (41.2) |
| Male | 20 (58.8) |
| Karnofsky performance score at diagnosis | |
| Median | 90 |
| Extent of primary resection—n (%) | |
| Complete | 17 (50.0) |
| Partial | 6 (17.6) |
| Open biopsy | 11 (32.4) |
| IDH-mutation status—n (%) | |
| Wildtype | 33 (97.1) |
| Mutated | 1 (2.9) |
| MGMT promoter status—n (%) | |
| Methylated | 11 (32.4) |
| Non-methylated | 6 (17.6) |
| Not determined | 17 (50.0) |
| Progression-free survival | |
| Median (months) | 22.4 |
| Overall survival | |
| Median (months) | 35.8 |
IDH Isocitratdehydrogenase genes 1/2, MGMT 06-Methyl-guanine-methyltransferase gene